2022
## Burma Skincare Initiative
## REPORT AND AUDITED ACCOUNTS
## Contents
|Trustees’ Report and Financial Statements for the period 1 April 2021 to 31 March 2022|2|
|---|---|
|Objectives and Activities of the Burma Skincare Initiative|3|
|Financial Review|6|
|Structure Governance and Management|7|
|Statement of Trustees’ responsibilities|8|
|Independent Examiner's Report
|9|
|Receipts and Payments Accounts
|10|
1
Trustees’ Report and Financial Statements for the period 1 April 2021 to 31 March 2022
Registered Charity Number 1187197
Principal Office:
4 Fitzroy Square London W1T 5HQ
Trustees at the date this report was approved Professor Christopher Griffiths (Chair) Mr Stephen Lue Dr Su Lwin
Bankers NatWest plc
Independent Examiner Delta Solutions 3 Wellgreen Close Hale Altrincham WA15 8PT
2
## Objectives and Activities of the Burma Skincare Initiative
## Overview
The Burma Skincare Initiative (BSI) is a small charity, founded in 2020, that has as its overarching mission the promotion of skincare excellence for the people of Burma (Myanmar). A particular focus is on skincare provision to the disadvantaged and displaced people of Burma. It is an active and sustainable collaboration between dermatologists and dermatology nurses based predominantly in the UK with their colleagues in Burma. The BSI’s strategy is founded on the three pillars of: education, research and clinical care articulated via a 10-year strategic plan focused on short, medium, and long-term goals.
## Objectives and Activities of the BSI
The BSI has the following objectives:
## _Short-term:_
To run an inaugural BSI dermatology meeting in Yangon, Burma (Myanmar). Establish travel and exchange fellowships for doctors and nurses and virtual case conferences. To set up research studies on diagnosis and management of mycetoma. To establish a fully functional website for the charity.
## _Medium-term:_
To provide regular BSI meetings and training in diagnosis and management of skin disease by community nurses and healthcare workers in township hospitals with aid of educational videos and teledermatology. To design and run a skin disease survey in Burma and to establish a diagnostics service for immunobullous diseases. To work with colleagues to establish rural skincare clinics.
## _Long-term:_
To establish a regional dermatology training and research centre in Burma
## Achievements and Performance
In the reporting year 1 April 2022 to 31 March 2022 the ongoing COVID pandemic (see below) and the military coup d’état in Burma on 1 February 2021 necessitated important changes to the charity’s strategy to enable it continue to fulfil its objectives. This was because these two major events prevented any travel to Burma and the border remained closed to the BSI during the reporting period. Targeting of healthcare facilities and healthcare personnel by the military led to closure of specialist services and medical training and a rapid dispersal of the dermatology workforce in Burma with a consequent disintegration of specialist skincare provision in the country. This shifted the burden of
3
diagnosing and managing skin disease in Burma to non-specialist frontline healthcare workers (FHCWs). The BSI addressed this crisis situation under the umbrella term of “Essential Emergency Skincare” (EES) by revising delivery of its objectives so as to taskshare skincare provision away from dermatologically-trained experts to Myanmar FHCWs such as community nurses and medical students This was achieved in the reporting period through: development and implementation of one-page diagnostic/management flowcharts on 10 skin diseases; delivery of UK multi-disciplinary-led webinars on the management of common skin diseases in adults and children for nurses, dermatologists, medical students and GPs in Burma; and inclusion of dermatology in the revised undergraduate medical curriculum. We are continuing to build on this with further initiatives in 2022-23. The EES framework ensures sustainability of skincare in Burma during a national crisis which has been achieved through task-sharing – delegation of healthcare provision to FHCWs. The BSI has bridged gaps in, and sustained delivery of, education, training, and skincare services during the COVID-19 pandemic and the coup d’état.
April 2021 Dr Lwin provided an online lecture about the BSI and the situation in Burma to the St John’s Institute of Dermatology, London weekly meeting attended by 44 dermatologists and nurses including colleagues from Lubeck, Germany.
October 2021 Dr Lwin delivered an update about the work of the BSI to the BAD Global Health Dermatology meeting held online to 40 international and UK dermatologists.
November 2021 Prof Griffiths delivered an online lecture about skincare in Myanmar at the International Society of Dermatology World Congress. This was viewed by 100 attendees.
November 2021 A Reunion for “Friends of the BSI” was held in person at the British Association of Dermatologists headquarters in London. The event was attended by 35 supporters, and we were joined online by others unable to travel to London for the event and by colleagues from Yangon, Burma. The three Trustees of the BSI provided verbal updates to the gathering about the achievements of the Charity in the previous year.
January 2022 Prof Griffiths and Dr Lwin delivered an online update on the BSI and its activities to 15 Dermatology trainees at Salford Royal Hospital
Free online registrations awarded to 6 Burmese dermatologists to attend the Psoriasis from Gene to Clinic Congress in December 2021
Free online registrations awarded to 4 Burmese dermatologists to attend the online European Society for Dermatology meeting in September 2021
4
Prof Griffiths and Dr Lwin worked closely with the Tropical Health and Education Trust Myanmar team to advise on issues relating to healthcare and healthcare workers in Burma following the coup d’état in February 2021.
_Publications:_
British Association of Dermatologists Winter Newsletter 2021 – work of the BSI mentioned in report on global health.
Lwin SM, Griffiths CEM. Immediate global support is needed for Myanmar. British Journal of Dermatology 2021; 185:466-7
5
## Financial Review
The spread of Covid-19 into Burma in late February 2020 curtailed any on the ground activities by the BSI team during the reporting period and the impact has been felt into the current financial year.
Income totalling £10,620 is from donations and this included the receipt of £10,000 from Almirall Ltd restricted to the expenditure on the development of educational materials.
Expenditure at this early stage in the life of the charity is carefully controlled. The annual expenditure was £5,242 broken down as:
|was £5,242 broken down as:||
|---|---|
|Charitable activity: Raising awareness|£1,581|
|Fundraising costs|£616|
|Accountancy fees|£324|
|Admin staff costs|£2,721|
6
## Structure Governance and Management
## Trustees during the year covered by this report
Professor Christopher Griffiths (Chair), Stephen Lue and Dr Su Lwin all are founder trustees of the charity
The current Trustees and their areas of responsibility are given below:
Professor Christopher Griffiths (Chair) Mr Stephen Lue (Trustee) Dr Su Lwin (Trustee)
## Governance
The Trustees have developed:
- a vision and mission statement for the BSI;
- a robust policy framework including policies on:
- Risk Management
- Investment
- Safeguarding vulnerable beneficiaries
- Conflicting Interests
- Complaint Handling
- a five-year business plan;
- a strategic plan for the next 10 years; and
- a Trustee register of skills and interests.
The Trustees receive regular formal training on their responsibilities.
The Trustees have overall responsibility for the day-to-day management of the BSI and meet regularly to discuss matters and to make decisions affecting the charity.
A risk assessment has been prepared and reviewed by the Trustees. Policies and procedures have been formalised so that any risks can be identified, actively managed and where possible, mitigated.
7
## Statement of Trustees’ responsibilities
In the attached accounts set out on pages xx to xx, the Trustees have prepared financial statements for the period up to 31 March 2021. In preparing such statements the Trustees are required to:
- select suitable accounting policies and apply them consistently.
- make judgements and estimates that are reasonable and prudent;
- state whether applicable accounting standards and statements of recommended practice have been followed, subject to any departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume the Foundation will continue in its operational existence.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at the time the financial position of the Foundation and to enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the Foundation and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
## Jan 12, 2023
The report was approved by the trustees on ______________ and signed on its behalf by:
Su Lwin (Jan 12, 2023 22:07 GMT)
Professor Christopher Griffiths Dr Su Lwin Chair Trustee
8
## **Independent Examiner’s Report**
|**Report to the trustees/**
**members of**
**On accounts for the**
**period**
**Set out on pages**|Burma Skincare Initiative|Burma Skincare Initiative|Burma Skincare Initiative|
|---|---|---|---|
|||||
||1 April 2021 to 31 March 2022|**Charity no**
**(if any)**|1187197|
|||||
||10 to 11|||
I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the period ended 31/03/2021.
**Responsibilities and** As the charity trustees of the Trust, you are responsible for the preparation **basis of report** of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).
I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
**Independent** I have completed my examination. I confirm that no material matters have **examiner's statement** come to my attention in connection with the examination which gives me cause to believe that in, any material respect:
- accounting records were not kept in accordance with section 130 of the Act or
- the accounts do not accord with the accounting records
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached.
|**Signed:**
**Name:**
**Relevant professional**
**qualification(s) or body**
**(if any):**
**Address:**
|s Weighell(Jan 13,2023 06:03 GMT)
s Weighell|Jan 13,2023|
|---|---|---|
||||
||Susan Weighell||
||||
||FCA||
||||
||3 Wellgreen Close, Hale||
||Altrincham||
||WA15 8PT||
9
**1187197**
## **Burma Skincare Initiative**
## **Receipts and payments accounts**
**For the**
## **period from**
**01/04/2021**
**To**
**31/03/2022**
## **Section A Receipts and payments**
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**620**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Unrestricted**
**funds**
**to the nearest £**
**620**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Restricted**
**funds**
**to the nearest £**
**10,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Restricted**
**funds**
**to the nearest £**
**10,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**10,620**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**10,620**
**-**
**-**|**Total funds**
**to the nearest £**
**10,620**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**10,620**
**-**
**-**|**Last year**
**to the nearest £**|
|---|---|---|---|---|---|---|---|---|---|
|Donations|**620**||**10,000**||**-**||**10,620**||**30,774**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|**620**||**10,000**||**-**||**10,620**||**30,774**|
||**-**
**-**
**-**
**620**
**616**
**324**
**1,581**
**2,722**
**-**
**-**
**-**
**-**
**-**
**5,242**
**-**
**-**
**-**
**5,242**
**- 4,622**
**-**
**30,774**
**26,151**||**-**
**-**
**-**
**10,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**10,000**
**-**
**-**
**10,000**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|||||
|**A2 Asset and investment sales,**
**(see table).**||||||||||
||**-**||||||**-**|||
||**-**||||||**-**||**-**|
|**_Sub total_**|**-**||||||**-**||**-**|
|**_Total receipts_**
**A3 Payments**|||||||**10,620**
**616**
**324**
**1,581**
**2,722**
**-**
**-**
**-**
**-**
**-**
**5,242**
**-**
**-**
**-**
**5,242**
**5,378**|||
||||||||||**30,774**|
|||||||||||
|
Fundraisingcosts|**616**||||||||**-**|
|Accountancyfees|**324**||||||||**-**|
|CA: Raisingawareness|**1,581**||||||||**-**|
|Admin staff costs|**2,722**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
|**_Sub total_ **|**5,242**||||||||**-**|
|||||||||||
|**A4 Asset and investment**
**purchases, (see table)**||||||||||
||**-**|||||||||
||**-**|||||||||
|**_Sub total_ **|**-**||||||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||||||
||||||||||**-**|
|||||||||||
||**- 4,622**||**10,000**||**-**||**5,378**||**30,774**|
||**-**||**-**||**-**||**-**||**-**|
||**30,774**||**-**||**-**||**30,774**||**-**|
||**26,151**||**10,000**||**-**||**36,151**||**30,774**|
10
|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|---|
|**Categories**
Signed on behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
Bank account
**Details**
**Details**
**Details**
Signature
SuLwin(Jan 12,202322:07GMT)
Su Lwin(Jan 12,2023 22:07 GMT)|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**36,151**
**-**
**-**
**-**
**-**
**-**
**36,151**
**-**
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Professor Christopher Griffiths
Dr Su Lwin|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**||**Endowment**
**funds**
**to nearest £**|
||||**-**||**30,774**|
||||**-**||**-**|
||||**-**||**-**|
||||**-**||**30,774**|
||||||**Endowment**
**funds**
**to nearest £**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**Current value**
**(optional)**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**Current value**
**(optional)**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**-**|
||||||**When due**
**(optional)**|
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
||||||Date of
approval|
||SuLwin(Jan 12,202322:07GMT)|Professor Christopher Griffiths|||Jan 12,2023|
||Su Lwin(Jan 12,2023 22:07 GMT)|Dr Su Lwin|||Jan 12,2023|
11